Clincosm LogoSign in Get a demo

prolymphocytic leukemia

Showing 26 - 44 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prolymphocytic Leukemia Trial in Austria, Germany (alemtuzumab, cyclophosphamide, fludarabine phosphate)

Completed
  • Prolymphocytic Leukemia
  • alemtuzumab
  • +3 more
  • Vienna, Austria
  • +18 more
May 9, 2018

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2018

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Seattle, Torino (drug, procedure,

Completed
Has Results
  • B-Cell Prolymphocytic Leukemia
  • +6 more
  • Seattle, Washington
  • +2 more
Dec 5, 2017

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +41 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 22, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +178 more
  • fludarabine phosphate
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma Trial (sotrastaurin acetate,

Withdrawn
  • Prolymphocytic Leukemia
  • +4 more
  • sotrastaurin acetate
  • +2 more
  • (no location specified)
Apr 3, 2017

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Aug 31, 2016

B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cancer, Prolymphocytic Leukemia Trial in Columbus (carfilzomib,

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
    Ohio State University Medical Center
May 6, 2016

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Terminated
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Alvocidib Hydrochloride
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 10, 2015

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • alvespimycin hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 3, 2015

Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial

Unknown status
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • anti-CD20-CAR vector-transduced autologous T cells
  • genetically engineered lymphocyte therapy
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Sep 27, 2015

Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Columbus (Alvocidib Hydrochloride, Lenalidomide,

Completed
  • Anemia
  • +5 more
  • Alvocidib Hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 1, 2015

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +7 more
  • obatoclax mesylate
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 27, 2013

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +80 more
  • imatinib mesylate
  • pharmacological study
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 6, 2013

MALT, Nodal Marginal Zone B-cell Lymphoma, Prolymphocytic Leukemia Trial in New York (arsenic trioxide, laboratory biomarker

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +10 more
  • arsenic trioxide
  • laboratory biomarker analysis
  • New York, New York
    Mount Sinai Medical Center
Jan 31, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +102 more
  • management of therapy complications
  • musculoskeletal complications management/prevention
  • (no location specified)
Jul 5, 2012